AnchorBio Solutions

AnchorBio Solutions is a private, early-revenue-stage CRO offering specialized preclinical services to biopharma and diagnostics companies. Leveraging a team of seasoned scientists with decades of experience, the company provides end-to-end support from target identification and validation through screening, protein engineering, and antibody development. Its business model is purely service-based, operating as a capital-light partner for clients, with a focus on scientific expertise, quality data, and project flexibility to adapt to evolving research needs.

Integrated service infrastructure specializing in custom assay development, protein/antibody engineering & production, and cell biology, supported by modern biochemistry/molecular biology labs and a rodent vivarium.

AnchorBio competes in the fragmented preclinical CRO market against large players like Charles River Laboratories and Eurofins, as well as numerous niche biology-focused boutiques. Its differentiation hinges on a partnership model, deep expertise in protein/antibody services, and flexibility, rather than scale or global reach.